Oral Protein and Peptides Market Size to Hit USD 47.63 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Oral Protein and Peptides Market

5.1. COVID-19 Landscape: Oral Protein and Peptides Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Oral Protein and Peptides Market, By Product Type

8.1. Oral Protein and Peptides Market Revenue and Volume Forecast, by Product Type

8.1.1. Nutritional Proteins

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Bioactive Peptides

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Therapeutic Peptides

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Oral Protein and Peptides Market, By Source

9.1. Oral Protein and Peptides Market Revenue and Volume Forecast, by Source

9.1.1. Animal-Derived Proteins

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Plant-Derived Proteins 9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Synthetic / Fermentation-Derived Peptides

9.1.3.1. Market Revenue and Volume Forecast

9.1.3.2 Collagen-Derived Peptides

9.1.4. Market Revenue and Volume Forecast

Chapter 10. Global Oral Protein and Peptides Market, By Application

10.1. Oral Protein and Peptides Market Revenue and Volume Forecast, by Application

10.1.1. Sports & Performance Nutrition

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Weight Management

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Immune Health Support

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Digestive & Gut Health

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Bone & Joint Health

10.1.5.1. Market Revenue and Volume Forecast

10.1.6.2 Metabolic Health

10.1.6. Market Revenue and Volume Forecast

10.1.7.1 Therapeutic / Clinical Nutrition

10.1.7.1 Market Revenue and Volume Forecast

10.1.8.2 Other Functional Applications

10.1.8. Market Revenue and Volume Forecast

Chapter 11. Global Oral Protein and Peptides Market, By End-User

11.1. Oral Protein and Peptides Market Revenue and Volume Forecast, by End-User

11.1.1. Sports & Fitness Enthusiasts

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Health & Wellness Consumers

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Medical & Clinical Nutrition Patients

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Aging Population / Elderly

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Lifestyle/Weight Management Users

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Oral Protein and Peptides Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by Source

12.1.3. Market Revenue and Volume Forecast, by Application

12.1.4. Market Revenue and Volume Forecast, by End-User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by Source

12.1.5.3. Market Revenue and Volume Forecast, by Application

12.1.5.4. Market Revenue and Volume Forecast, by End-User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by Source

12.1.6.3. Market Revenue and Volume Forecast, by Application

12.1.6.4. Market Revenue and Volume Forecast, by End-User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by Source

12.2.3. Market Revenue and Volume Forecast, by Application

12.2.4. Market Revenue and Volume Forecast, by End-User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by Source

12.2.5.3. Market Revenue and Volume Forecast, by Application

12.2.5.4. Market Revenue and Volume Forecast, by End-User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by Source

12.2.6.3. Market Revenue and Volume Forecast, by Application

12.2.6.4. Market Revenue and Volume Forecast, by End-User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by Source

12.2.7.3. Market Revenue and Volume Forecast, by Application

12.2.7.4. Market Revenue and Volume Forecast, by End-User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by Source

12.2.8.3. Market Revenue and Volume Forecast, by Application

12.2.8.4. Market Revenue and Volume Forecast, by End-User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by Source

12.3.3. Market Revenue and Volume Forecast, by Application

12.3.4. Market Revenue and Volume Forecast, by End-User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by Source

12.3.5.3. Market Revenue and Volume Forecast, by Application

12.3.5.4. Market Revenue and Volume Forecast, by End-User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by Source

12.3.6.3. Market Revenue and Volume Forecast, by Application

12.3.6.4. Market Revenue and Volume Forecast, by End-User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by Source

12.3.7.3. Market Revenue and Volume Forecast, by Application

12.3.7.4. Market Revenue and Volume Forecast, by End-User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by Source

12.3.8.3. Market Revenue and Volume Forecast, by Application

12.3.8.4. Market Revenue and Volume Forecast, by End-User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by Source

12.4.3. Market Revenue and Volume Forecast, by Application

12.4.4. Market Revenue and Volume Forecast, by End-User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by Source

12.4.5.3. Market Revenue and Volume Forecast, by Application

12.4.5.4. Market Revenue and Volume Forecast, by End-User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by Source

12.4.6.3. Market Revenue and Volume Forecast, by Application

12.4.6.4. Market Revenue and Volume Forecast, by End-User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by Source

12.4.7.3. Market Revenue and Volume Forecast, by Application

12.4.7.4. Market Revenue and Volume Forecast, by End-User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by Source

12.4.8.3. Market Revenue and Volume Forecast, by Application

12.4.8.4. Market Revenue and Volume Forecast, by End-User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by Source

12.5.3. Market Revenue and Volume Forecast, by Application

12.5.4. Market Revenue and Volume Forecast, by End-User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by Source

12.5.5.3. Market Revenue and Volume Forecast, by Application

12.5.5.4. Market Revenue and Volume Forecast, by End-User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by Source

12.5.6.3. Market Revenue and Volume Forecast, by Application

12.5.6.4. Market Revenue and Volume Forecast, by End-User

Chapter 13. Company Profiles

13.1. Novo Nordisk

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProduct Typeance

13.1.4. Recent Initiatives

13.2. Eli Lilly

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProduct Typeance

13.2.4. Recent Initiatives

13.3. Pfizer

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProduct Typeance

13.3.4. Recent Initiatives

13.4. AbbVie

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProduct Typeance

13.4.4. Recent Initiatives

13.5. Zealand Pharma

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProduct Typeance

13.5.4. Recent Initiatives

13.6. Oramed Pharmaceuticals

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProduct Typeance

13.6.4. Recent Initiatives

13.7. Entera Bio

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProduct Typeance

13.7.4. Recent Initiatives

13.8. Bachem

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProduct Typeance

13.8.4. Recent Initiatives

13.9. Lonza

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProduct Typeance

13.9.4. Recent Initiatives

13.10. Catalent

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProduct Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The oral protein and peptide market size is expected to increase from USD 9.43 billion in 2025 to USD 47.63 billion by 2035.

Answer : The oral protein and peptide market is expected to grow at a compound annual growth rate (CAGR) of around 17.58% from 2026 to 2035.

Answer : The driving factors of the oral protein and peptide market are the increasing burden of chronic diseases and higher demand for convenient, non-invasive oral medications over traditional injections, which improves patient adherence and quality of life.

Answer : North America region will lead the global oral protein and peptide market during the forecast period 2026 to 2035.